Chemicals · Founded 1973 · www.gacl.com · BSE 530001 · NSE GUJ.ALKALI · ISIN INE186A01019
No Notes Added Yet
Business
Gujarat Alkalies And Chemicals Ltd. (GUJALKALI) is a leading manufacturer of industrial chemicals in India. The company's core business revolves around the production of Chlor-Alkali products and their derivatives. It operates large-scale, integrated manufacturing facilities to produce a wide range of chemicals including Caustic Soda (liquid, flakes, prills), Chlorine, Hydrochloric Acid, Chloromethanes, Phosphoric Acid, Hydrogen Peroxide, and various other industrial chemicals. The company primarily makes money by selling these essential chemicals to diverse end-user industries such as textiles, paper & pulp, alumina, water treatment, pharmaceuticals, and agricultural sectors.
Revenue Mix
GUJALKALI's revenue is primarily derived from its two major manufacturing complexes producing a broad portfolio of chemicals. While specific percentage breakdowns are not always readily disclosed, the bulk of its revenue comes from:
Chlor-Alkali Products: This segment includes Caustic Soda (major product), Chlorine, and Hydrochloric Acid. These are fundamental building blocks for many industries.
Chlorine Derivatives & Other Chemicals: This segment encompasses a range of downstream products utilizing chlorine, such as Chloromethanes (Methylene Chloride, Chloroform, Carbon Tetrachloride), Aluminium Chloride, Poly Aluminium Chloride, Hydrogen Peroxide, Phosphoric Acid, and others.
Industry
GUJALKALI operates within the Indian chemicals industry, specifically in the basic inorganic chemicals and bulk chemicals segment. This industry is capital-intensive, power-intensive, and largely commodity-driven, making it susceptible to cyclical demand and pricing. GUJALKALI is one of the largest producers of Caustic Soda and other Chlor-Alkali products in India. It holds a significant market share and benefits from its long-standing presence and established relationships within the industrial ecosystem. The company faces competition from other major domestic players like Grasim Industries (Aditya Birla Chemicals), DCM Shriram, and Nirma.
MOAT
GUJALKALI possesses several competitive advantages:
Scale and Integration: Large-scale, integrated manufacturing facilities allow for cost efficiencies in production and backward/forward integration of processes, enabling utilization of by-products like chlorine.
Established Market Position: A long operational history and significant capacity in key products like Caustic Soda provide a strong market presence and customer base.
Government Backing: As a company promoted by the Government of Gujarat, it may benefit from certain state-level incentives, policy support, and stability, though it operates professionally.
Geographic Advantage: Its manufacturing units are strategically located in Gujarat, an industrial hub with good infrastructure and proximity to raw material sources and key consuming industries.
Growth Drivers
Key factors that can drive growth for GUJALKALI over the next 3-5 years include:
Demand from End-Use Industries: Continued growth in sectors such as alumina, paper, textiles, automotive, pharma, and water treatment will drive demand for its core chemical products.
Capacity Expansions: Ongoing or planned expansion projects for key products like Caustic Soda, as well as diversification into new derivatives or higher-value-added chemicals, will contribute to volume growth.
Backward/Forward Integration: Initiatives to enhance efficiency, reduce costs, and capture more value across the production chain.
Infrastructure Development: Government focus on infrastructure development and manufacturing growth in India fuels demand for basic chemicals.
Sustainability Initiatives: Investment in green technologies, renewable energy sources, and efficient processes can lead to cost savings and compliance with evolving environmental standards.
Risks
GUJALKALI faces several business risks:
Commodity Price Volatility: Prices of key raw materials (e.g., common salt, power, coal/fuel) and finished products (e.g., Caustic Soda) are subject to global and domestic demand-supply dynamics, leading to margin fluctuations.
High Power Costs: Chemical manufacturing is energy-intensive; fluctuations in power tariffs or availability can significantly impact profitability.
Intense Competition: The presence of several large domestic players creates pricing pressure and limits market share expansion.
Environmental Regulations: Stringent environmental norms and compliance costs related to effluent treatment, waste management, and emissions can increase operational expenses.
Cyclicality of End-User Industries: A downturn in key consuming sectors can directly impact demand for GUJALKALI's products.
Foreign Exchange Fluctuations: While primarily domestic, some imports of raw materials or exports can expose the company to currency risks.
Management & Ownership
Gujarat Alkalies And Chemicals Ltd. is a Government of Gujarat undertaking. The Government of Gujarat holds a significant majority stake (approximately 46% as of recent data), making it the promoter. The management team comprises professional executives appointed by the board, which typically includes nominees from the state government and independent directors. The company's operations are managed by experienced personnel in the chemical industry.
Outlook
GUJALKALI stands as a well-established and significant player in India's basic chemicals sector, particularly in Chlor-Alkali. The company benefits from a large scale of operations, integrated facilities, and sustained demand from diverse industrial sectors. Its strategic expansions and focus on efficiency improvements present growth opportunities. However, its performance is inherently linked to the cyclical nature of commodity chemicals, volatility in input costs, and intense competition. The high energy consumption of its processes remains a key operating leverage point and risk. While its promoter backing provides stability, the company needs to continuously innovate and manage cost efficiencies to navigate the dynamic and competitive chemical landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 971 | 921 | 1002 | 977 | 991 | 1029 | 1075 | 1105 | 1083 | 1044 |
| Other Income | 71 | 5 | 3 | 3 | 49 | 15 | 24 | 8 | 59 | 30 |
| Total Income | 1042 | 926 | 1004 | 981 | 1040 | 1045 | 1100 | 1114 | 1142 | 1075 |
| Total Expenditure | 926 | 914 | 973 | 904 | 916 | 931 | 962 | 989 | 1009 | 940 |
| Operating Profit | 116 | 12 | 31 | 77 | 124 | 113 | 138 | 125 | 133 | 135 |
| Interest | 11 | 11 | 12 | 11 | 11 | 10 | 18 | 14 | 16 | 18 |
| Depreciation | 95 | 96 | 97 | 97 | 100 | 98 | 97 | 102 | 104 | 104 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | -95 | -77 | -30 | 13 | 4 | 23 | 10 | 13 | 13 |
| Provision for Tax | -0 | -7 | -56 | -6 | 2 | -4 | 1 | 2 | -3 | 24 |
| Profit After Tax | 10 | -88 | -21 | -25 | 11 | 9 | 21 | 8 | 16 | -11 |
| Adjustments | -29 | -27 | -25 | -20 | -29 | -20 | -13 | -22 | 0 | -9 |
| Profit After Adjustments | -18 | -115 | -46 | -45 | -18 | -11 | 9 | -14 | 16 | -20 |
| Adjusted Earnings Per Share | -2.5 | -15.7 | -6.3 | -6.1 | -2.5 | -1.5 | 1.2 | -1.9 | 2.2 | -2.7 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1995 | 2070 | 2455 | 3161 | 2725 | 2429 | 3759 | 4517 | 3807 | 4073 | 4307 |
| Other Income | 46 | 58 | 106 | 61 | 90 | 67 | 46 | 42 | 90 | 92 | 121 |
| Total Income | 2042 | 2128 | 2560 | 3222 | 2814 | 2497 | 3805 | 4559 | 3897 | 4165 | 4431 |
| Total Expenditure | 1662 | 1623 | 1668 | 2046 | 2147 | 2071 | 2773 | 3402 | 3671 | 3712 | 3900 |
| Operating Profit | 380 | 506 | 892 | 1176 | 667 | 426 | 1033 | 1157 | 226 | 453 | 531 |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 66 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 407 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 262 | 381 | 749 | 1016 | 491 | 235 | 826 | 695 | -300 | -71 | 59 |
| Provision for Tax | 43 | 73 | 215 | 326 | 159 | 69 | 267 | 285 | -64 | -6 | 24 |
| Profit After Tax | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | 34 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -44 |
| Profit After Adjustments | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | -9 |
| Adjusted Earnings Per Share | 29.9 | 41.8 | 72.8 | 94 | 45.2 | 22.6 | 76.2 | 55.8 | -32.3 | -8.9 | -1.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 3% | 8% | 0% |
| Operating Profit CAGR | 100% | -24% | -7% | 0% |
| PAT CAGR | 0% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 15% | 2% | 11% | 13% |
| ROE Average | -1% | 1% | 3% | 7% |
| ROCE Average | -0% | 2% | 5% | 10% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2928 | 3356 | 3821 | 4296 | 4596 | 5375 | 5899 | 6139 | 6076 | 5670 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 222 | 284 | 230 | 185 | 137 | 433 | 549 | 459 | 343 | 309 |
| Other Non-Current Liabilities | 396 | 387 | 441 | 543 | 630 | 735 | 794 | 897 | 861 | 1074 |
| Total Current Liabilities | 348 | 409 | 478 | 508 | 528 | 611 | 735 | 840 | 745 | 933 |
| Total Liabilities | 3894 | 4435 | 4970 | 5531 | 5891 | 7154 | 7977 | 8335 | 8023 | 7987 |
| Fixed Assets | 1821 | 2073 | 2104 | 2300 | 2610 | 2587 | 2702 | 4250 | 4617 | 4584 |
| Other Non-Current Assets | 1177 | 1349 | 1591 | 1621 | 1909 | 3479 | 4182 | 2675 | 2493 | 2348 |
| Total Current Assets | 896 | 1013 | 1275 | 1610 | 1372 | 1089 | 1094 | 1410 | 913 | 1055 |
| Total Assets | 3894 | 4435 | 4970 | 5531 | 5891 | 7154 | 7977 | 8335 | 8023 | 7987 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 86 | 19 | 68 | 71 | 192 | 42 | 355 | 298 | 456 | 155 |
| Cash Flow from Operating Activities | 201 | 502 | 514 | 838 | 630 | 421 | 735 | 960 | 67 | 381 |
| Cash Flow from Investing Activities | -352 | -467 | -395 | -583 | -635 | -332 | -805 | -661 | -90 | -264 |
| Cash Flow from Financing Activities | 84 | 13 | -116 | -136 | -146 | 226 | 12 | -140 | -277 | -145 |
| Net Cash Inflow / Outflow | -67 | 49 | 3 | 119 | -151 | 315 | -59 | 159 | -301 | -28 |
| Closing Cash & Cash Equivalent | 19 | 68 | 71 | 192 | 42 | 355 | 298 | 456 | 155 | 126 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 29.9 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -8.87 |
| CEPS(Rs) | 44.53 | 56.95 | 90.12 | 113.04 | 67.26 | 46.31 | 103.16 | 93.37 | 19.14 | 44.55 |
| DPS(Rs) | 4.5 | 5 | 6.5 | 8 | 8 | 8 | 10 | 23.55 | 13.85 | 15.8 |
| Book NAV/Share(Rs) | 398.68 | 456.95 | 520.31 | 584.93 | 625.8 | 731.87 | 803.32 | 835.99 | 827.31 | 772.03 |
| Core EBITDA Margin(%) | 15.05 | 19.43 | 31.29 | 35.27 | 21.2 | 14.74 | 26.24 | 24.68 | 3.57 | 8.85 |
| EBIT Margin(%) | 12.28 | 17.09 | 30.4 | 32.81 | 18.53 | 10.3 | 22.15 | 15.82 | -6.72 | -0.51 |
| Pre Tax Margin(%) | 11.83 | 16.53 | 29.81 | 32.15 | 18.02 | 9.66 | 21.99 | 15.39 | -7.89 | -1.75 |
| PAT Margin (%) | 9.9 | 13.35 | 21.26 | 21.83 | 12.19 | 6.82 | 14.89 | 9.07 | -6.22 | -1.6 |
| Cash Profit Margin (%) | 14.74 | 18.16 | 26.33 | 26.26 | 18.13 | 14 | 20.15 | 15.18 | 3.69 | 8.03 |
| ROA(%) | 5.64 | 7.38 | 11.37 | 13.14 | 5.82 | 2.54 | 7.4 | 5.02 | -2.9 | -0.81 |
| ROE(%) | 7.5 | 9.78 | 14.9 | 17.01 | 7.47 | 3.32 | 9.93 | 6.81 | -3.88 | -1.11 |
| ROCE(%) | 8.45 | 11.35 | 19.55 | 23.97 | 10.81 | 4.69 | 13.47 | 10.8 | -3.83 | -0.32 |
| Receivable days | 53.71 | 51.93 | 53.14 | 51.4 | 57.69 | 49.82 | 28.72 | 23.73 | 22.16 | 19.75 |
| Inventory Days | 30.38 | 28.1 | 31.61 | 28.69 | 31.33 | 34.7 | 28.11 | 32.89 | 41.61 | 40.03 |
| Payable days | 99.22 | 113.97 | 139.76 | 126.51 | 123.84 | 118.1 | 90.65 | 102.36 | 99.5 | 99.54 |
| PER(x) | 5.52 | 9.72 | 9.61 | 5.25 | 4.94 | 15.27 | 11.75 | 10.55 | 0 | 0 |
| Price/Book(x) | 0.41 | 0.89 | 1.34 | 0.84 | 0.36 | 0.47 | 1.12 | 0.7 | 0.81 | 0.75 |
| Dividend Yield(%) | 2.73 | 1.23 | 0.93 | 1.62 | 3.58 | 2.32 | 1.12 | 4 | 2.06 | 2.73 |
| EV/Net Sales(x) | 0.73 | 1.55 | 2.16 | 1.14 | 0.66 | 1.1 | 1.83 | 0.98 | 1.4 | 1.15 |
| EV/Core EBITDA(x) | 3.83 | 6.35 | 5.93 | 3.06 | 2.7 | 6.27 | 6.66 | 3.83 | 23.55 | 10.32 |
| Net Sales Growth(%) | 0 | 3.75 | 18.56 | 28.8 | -13.82 | -10.83 | 54.71 | 20.16 | -15.72 | 7 |
| EBIT Growth(%) | 0 | 44.45 | 94.28 | 35.7 | -51.32 | -50.46 | 232.82 | -14.17 | -135.81 | 91.92 |
| PAT Growth(%) | 0 | 39.93 | 73.93 | 29.13 | -51.88 | -50.09 | 237.74 | -26.82 | -157.82 | 72.51 |
| EPS Growth(%) | 0 | 39.93 | 73.93 | 29.13 | -51.88 | -50.09 | 237.74 | -26.82 | -157.82 | 72.51 |
| Debt/Equity(x) | 0.1 | 0.11 | 0.08 | 0.06 | 0.04 | 0.09 | 0.1 | 0.1 | 0.09 | 0.1 |
| Current Ratio(x) | 2.57 | 2.48 | 2.67 | 3.17 | 2.6 | 1.78 | 1.49 | 1.68 | 1.23 | 1.13 |
| Quick Ratio(x) | 2.04 | 2.06 | 2.11 | 2.71 | 2.15 | 1.41 | 1.01 | 1.13 | 0.68 | 0.61 |
| Interest Cover(x) | 27.44 | 30.66 | 51.31 | 49.53 | 35.96 | 16.18 | 135.46 | 36.72 | -5.74 | -0.41 |
| Total Debt/Mcap(x) | 0.24 | 0.12 | 0.06 | 0.07 | 0.12 | 0.2 | 0.09 | 0.14 | 0.11 | 0.13 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 47.28 |
| FII | 2.07 | 2.1 | 1.92 | 1.94 | 1.79 | 1.71 | 1.02 | 1.02 | 0.96 | 0.94 |
| DII | 2.17 | 3.14 | 3.46 | 3.76 | 4.14 | 4.17 | 4.34 | 4.53 | 4.75 | 3.73 |
| Public | 49.48 | 48.48 | 48.34 | 48.02 | 47.79 | 47.84 | 48.35 | 48.17 | 48.01 | 48.05 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.47 |
| FII | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 | 0.13 | 0.08 | 0.07 | 0.07 | 0.07 |
| DII | 0.16 | 0.23 | 0.25 | 0.28 | 0.3 | 0.31 | 0.32 | 0.33 | 0.35 | 0.27 |
| Public | 3.63 | 3.56 | 3.55 | 3.53 | 3.51 | 3.51 | 3.55 | 3.54 | 3.53 | 3.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +7% | +3% | +8% | — |
| Operating Profit CAGR | +100% | -24% | -7% | — |
| PAT CAGR | — | 0% | 0% | — |
| Share Price CAGR | +15% | +2% | +11% | +13% |
| ROE Average | -1% | +1% | +3% | +7% |
| ROCE Average | 0% | +2% | +5% | +10% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 46.28 | 47.28 |
| FII | 2.07 | 2.1 | 1.92 | 1.94 | 1.79 | 1.71 | 1.02 | 1.02 | 0.96 | 0.94 |
| DII | 2.17 | 3.14 | 3.46 | 3.76 | 4.14 | 4.17 | 4.34 | 4.53 | 4.75 | 3.73 |
| Public | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 53.72 | 52.72 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.4 | 3.47 |
| FII | 0.15 | 0.15 | 0.14 | 0.14 | 0.13 | 0.13 | 0.08 | 0.07 | 0.07 | 0.07 |
| DII | 0.16 | 0.23 | 0.25 | 0.28 | 0.3 | 0.31 | 0.32 | 0.33 | 0.35 | 0.27 |
| Public | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.87 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.